Zhuozhi Medical raises $3M angel round for objective pain measurement
What's the deal? Zhuozhi MedicalDealroom has a profile for this one. Try Dealroom → has raised a 20 million CNY (about $3 million) angel round to develop technology that objectively measures and treats pain. Zhongguancun Capital led the round, with Shanghai Changyao ShengboDealroom has a profile for this one. Try Dealroom → participating.
What's the endgame? The company is building what it calls a closed-loop system for pain management, framed around making pain "measurable" and "controllable." It first uses EEG and other signal-collection and decoding algorithms to solve how pain is measured, then applies neuromodulation techniques such as non-invasive spinal cord stimulation to treat it.
The result, the company says, is a full-chain solution covering pain assessment, intervention, and management.
Who's backing it? The investors combine state-linked credentials with healthcare industry resources, according to the company. That mix could give the startup access to both institutional support and sector connections as it moves from research to product.
The signal: Pain has long resisted objective measurement, leaving assessment reliant on patient self-reporting. Zhuozhi Medical's bet is that combining signal decoding with neuromodulation can turn a subjective experience into something clinicians can both quantify and adjust.
Image credit: Generated with Gemini
